Zopiclone (BioDeep_00000033306)

   

human metabolite blood metabolite Chemicals and Drugs Volatile Flavor Compounds


代谢物信息卡片


6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylic acid

化学式: C17H17ClN6O3 (388.1050602)
中文名称: 佐匹克隆
谱图信息: 最多检出来源 Homo sapiens(urine) 50%

Reviewed

Last reviewed on 2024-09-14.

Cite this Page

Zopiclone. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China. https://query.biodeep.cn/s/zopiclone (retrieved 2024-11-22) (BioDeep RN: BioDeep_00000033306). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

分子结构信息

SMILES: CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
InChI: InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3

描述信息

Zopiclone is only found in individuals that have used or taken this drug. It is a novel hypnotic agent used in the treatment of insomnia. Its mechanism of action is based on modulating benzodiazepine receptors. In addition to zopiclones benzodiazepine pharmacological properties it also has some barbiturate like properties. Zopiclone exerts its action by binding on the benzodiazepine receptor complex and modulation of the GABABZ receptor chloride channel macromolecular complex. Both zopiclone and benzodiazepines act indiscriminately at the benzodiazepine binding site on α1, α2, α3 and α5 GABAA containing receptors as full agonists causing an enhancement of the inhibitory actions of GABA to produce the therapeutic (hypnotic and anxiolytic) and adverse effects of zopiclone.
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

同义名列表

39 个代谢物同义名

6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylic acid; 6-(5-Chloro-2-pyridyl)-6,7-dihydro- 7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methyl-1- piperazinecarboxylate; 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate; 6-(5-chloropyridin-2-yl)-7-oxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate; Zopiclon-neuraxpharm; Zopiclon-ratiopharm; Zopiclon von CT; Ratio-zopiclone; Zopiclon stada; (+-)-Zopiclone; Zopiclon-teva; Zopiclon beta; Zopiclon abz; Nu-zopiclone; Zopiclon tad; Zopiclon azu; Zopiclodura; Zopiclon al; Zopiclonum; Zopi-puren; Zopiclona; Zimoclone; Zopicalma; zopiclone; Zorclone; Somnosan; Zimovane; Optidorm; Zopicalm; Imovane; Rhovane; Zopitan; Limovan; Ximovan; Zileze; Siaten; Amoban; Zop; Zopiclone



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Yongshuai Jing, Wenjing Cheng, Mingsong Li, Yameng Zhang, Xinyue Pang, Xiaoyue Qiu, Yuguang Zheng, Danshen Zhang, Lanfang Wu. Structural Characterization, Rheological Properties, Antioxidant and Anti-Inflammatory Activities of Polysaccharides from Zingiber officinale. Plant foods for human nutrition (Dordrecht, Netherlands). 2023 Mar; 78(1):160-165. doi: 10.1007/s11130-022-01033-7. [PMID: 36437417]
  • Kunihiro Iwamoto, Mari Iwata, Daiji Kambe, Yumiko Imadera, Naoki Tachibana, Yu Kajiyama, Masahiko Ando, Norio Ozaki. Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers. Psychopharmacology. 2022 Mar; 239(3):841-850. doi: 10.1007/s00213-022-06075-y. [PMID: 35106620]
  • Tong Wu, Ge Yu, Zhaoxia Li, Guijie Xin. Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease. Medicine. 2021 Jun; 100(25):e26243. doi: 10.1097/md.0000000000026243. [PMID: 34160387]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Szabolcs Sofalvi, Eric S Lavins, Claire K Kaspar, Haley M Michel, Christie L Mitchell-Mata, Marilyn A Huestis, Luigino G Apollonio. Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction. Journal of analytical toxicology. 2020 Oct; 44(7):708-717. doi: 10.1093/jat/bkaa072. [PMID: 32808043]
  • Linlin Fang, Yanyan Zhao, Chao Wang, Changyuan Wang, Xu Han, Pengjun Chen, Lizhu Zhao, Jingping Wang, Shuang Li, Zhen Jiang. Preparation of a thiols β-cyclodextrin/gold nanoparticles-coated open tubular column for capillary electrochromatography enantioseparations. Journal of separation science. 2020 Jun; 43(11):2209-2216. doi: 10.1002/jssc.201901323. [PMID: 32160391]
  • Chenning Zhang, Jialin Qu, Xiaoyuan Lv, Jianbin Zhang, Linlin Fang. A novel open-tubular capillary electrochromatography using carboxymethyl-β-cyclodextrin functionalized gold nanoparticles as chiral stationary phase. Journal of separation science. 2020 Mar; 43(5):946-953. doi: 10.1002/jssc.201900733. [PMID: 31802622]
  • Lina Dorthea Bruun, Kari Kjeldstadli, Vidar Temte, Morris Birdal, Liliana Bachs, Marit Langødegård, Dag Helge Strand, Kristin Irene Gaare, Elisabeth Øiestad, Gudrun Høiseth. Detection Time of Oxazepam and Zopiclone in Urine and Oral Fluid after Experimental Oral Dosing. Journal of analytical toxicology. 2019 Jun; 43(5):369-377. doi: 10.1093/jat/bky083. [PMID: 30615130]
  • Kai Zhao, Xiaoqian Luan, Yuntao Liu, Xinjie Tu, Huijun Chen, Huiping Shen, Huihua Qiu, Zhuoying Zhu, Jincai He. Low serum 25-hydroxyvitamin D concentrations in chronic insomnia patients and the association with poor treatment outcome at 2months. Clinica chimica acta; international journal of clinical chemistry. 2017 Dec; 475(?):147-151. doi: 10.1016/j.cca.2017.10.024. [PMID: 29080688]
  • C X Shu, D Gong, L P Zhang, J X Zhao. [Progress on Determination and Analysis of Zopiclone in Biological Samples]. Fa yi xue za zhi. 2017 Dec; 33(6):635-639. doi: 10.3969/j.issn.1004-5619.2017.06.014. [PMID: 29441774]
  • Amirah S Al-Attas, Jenny Jeehan Nasr, Shereen Shalan, Fathalla Belal. First derivative spectrofluorimetric determination of zopiclone and its degradation product, 2-amino-5-chloropyridine, in pharmaceutical formulations with preliminary tool in biological fluids for clinical evidence of zopiclone intake. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2017 Jun; 181(?):148-152. doi: 10.1016/j.saa.2017.03.036. [PMID: 28359903]
  • Beril Anilanmert, Fatma Çavuş, Ibrahim Narin, Salih Cengiz, Şefika Sertler, Ali Acar Özdemir, Münevver Açikkol. Simultaneous analysis method for GHB, ketamine, norketamine, phenobarbital, thiopental, zolpidem, zopiclone and phenytoin in urine, using C18 poroshell column. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2016 Jun; 1022(?):230-241. doi: 10.1016/j.jchromb.2016.03.040. [PMID: 27107852]
  • S-W Lai, H-C Lai, C-L Lin, K-F Liao. Zopiclone use associated with increased risk of acute pancreatitis: a case-control study in Taiwan. International journal of clinical practice. 2015 Nov; 69(11):1275-80. doi: 10.1111/ijcp.12689. [PMID: 26133234]
  • Yong-zhi Zhang, Hong-yuan He, Cai-meng She, Jie Lian. [Research Progress on Forensic Toxicology of Z-drugs]. Fa yi xue za zhi. 2015 Aug; 31(4):293-7. doi: . [PMID: 26665884]
  • Iris H S Chan, Auman C M Au, Jeffrey S S Kwok, Eudora Y D Chow, Michael H M Chan. Co-oximetry interference. Pathology. 2015 Jun; 47(4):392-3. doi: 10.1097/pat.0000000000000258. [PMID: 25938343]
  • Janne Nurminen, Juha Puustinen, Ritva Lähteenmäki, Tero Vahlberg, Alan Lyles, Markku Partinen, Ismo Räihä, Pertti J Neuvonen, Sirkka-Liisa Kivelä. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. BMC geriatrics. 2014 Nov; 14(?):121. doi: 10.1186/1471-2318-14-121. [PMID: 25416480]
  • Gunnel H Nilsson, Fredrik C Kugelberg, Johan Ahlner, Robert Kronstrand. Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-amino-5-chloropyridine in urine using LC-MS-MS. Journal of analytical toxicology. 2014 Jul; 38(6):327-34. doi: 10.1093/jat/bku042. [PMID: 24790062]
  • Juha Puustinen, Ritva Lähteenmäki, Päivi Polo-Kantola, Paula Salo, Tero Vahlberg, Alan Lyles, Pertti J Neuvonen, Markku Partinen, Ismo Räihä, Sirkka-Liisa Kivelä. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. European journal of clinical pharmacology. 2014 Mar; 70(3):319-29. doi: 10.1007/s00228-013-1613-6. [PMID: 24337417]
  • Sabina Strano Rossi, Luca Anzillotti, Erika Castrignanò, Giampietro Frison, Flavio Zancanaro, Marcello Chiarotti. UHPLC-MS/MS and UHPLC-HRMS identification of zolpidem and zopiclone main urinary metabolites and method development for their toxicological determination. Drug testing and analysis. 2014 Mar; 6(3):226-33. doi: 10.1002/dta.1470. [PMID: 23512850]
  • Deborah Montenarh, Markus Hopf, Hans H Maurer, Peter Schmidt, Andreas H Ewald. Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach. Analytical and bioanalytical chemistry. 2014 Jan; 406(3):803-18. doi: 10.1007/s00216-013-7513-x. [PMID: 24309624]
  • Naren Gunja. The clinical and forensic toxicology of Z-drugs. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2013 Jun; 9(2):155-62. doi: 10.1007/s13181-013-0292-0. [PMID: 23404347]
  • A K Tang, W K Tang, H J Liang, F Chan, S C Mak, G S Ungvari. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: a retrospective study. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan. 2012 Dec; 22(4):154-9. doi: NULL. [PMID: 23271584]
  • R N El-Shaheny, A Alattas, J J Nasr, N El-Enany, F Belal. Simultaneous determination of zopiclone and its degradation product and main impurity (2-amino-5-chloropyridine) by micellar liquid chromatography with time-programmed fluorescence detection: preliminary investigation for biological monitoring. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2012 Oct; 907(?):49-55. doi: 10.1016/j.jchromb.2012.08.034. [PMID: 22999478]
  • Stephanie J Marin, Mark Roberts, Michelle Wood, Gwendolyn A McMillin. Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma. Journal of analytical toxicology. 2012 Sep; 36(7):472-6. doi: 10.1093/jat/bks059. [PMID: 22833647]
  • Zi-ru Cheng, Li-ming Chen, Ming-hua Zhang. [Determination of zopiclone in serum by gas chromatographic method]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases. 2012 Apr; 30(4):314-5. doi: NULL. [PMID: 22804949]
  • Alberto Salomone, Enrico Gerace, Paola Brizio, M Carla Gennaro, Marco Vincenti. A fast liquid chromatography-tandem mass spectrometry method for determining benzodiazepines and analogues in urine. Validation and application to real cases of forensic interest. Journal of pharmaceutical and biomedical analysis. 2011 Nov; 56(3):582-91. doi: 10.1016/j.jpba.2011.06.007. [PMID: 21737221]
  • Daniela Remane, Markus R Meyer, Dirk K Wissenbach, Hans H Maurer. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Analytical and bioanalytical chemistry. 2011 Sep; 401(4):1341-52. doi: 10.1007/s00216-011-5187-9. [PMID: 21773738]
  • Milena Araújo Tonon, Valquíria A P Jabor, Pierina Sueli Bonato. Enantioselective analysis of zopiclone and its metabolites in plasma by liquid chromatography/tandem mass spectrometry. Analytical and bioanalytical chemistry. 2011 Jul; 400(10):3517-25. doi: 10.1007/s00216-011-5033-0. [PMID: 21547427]
  • L Asensi-Bernardi, Y Martín-Biosca, M J Medina-Hernández, S Sagrado. On the zopiclone enantioselective binding to human albumin and plasma proteins. An electrokinetic chromatography approach. Journal of chromatography. A. 2011 May; 1218(20):3111-7. doi: 10.1016/j.chroma.2011.03.025. [PMID: 21481885]
  • Gunnel H Nilsson, Fredrik C Kugelberg, Johan Ahlner, Robert Kronstrand. Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole blood. Forensic science international. 2011 Apr; 207(1-3):35-9. doi: 10.1016/j.forsciint.2010.08.016. [PMID: 20851542]
  • Monique A J Mets, Edmund R Volkerts, Berend Olivier, Joris C Verster. Effect of hypnotic drugs on body balance and standing steadiness. Sleep medicine reviews. 2010 Aug; 14(4):259-67. doi: 10.1016/j.smrv.2009.10.008. [PMID: 20171127]
  • Timothy P Rohrig, Melissa C Norton, Lydia A Harryman. Identification and quantitation of zopiclone in biological matrices using gas chromatography-mass spectrometry (GC-MS). Methods in molecular biology (Clifton, N.J.). 2010; 603(?):527-33. doi: 10.1007/978-1-60761-459-3_52. [PMID: 20077105]
  • Kim Huynh, Guohong Wang, Christine Moore, Rehka Barhate, Cynthia Coulter, Warren Rodrigues, Philip Catbagan, James Soares. Development of a homogeneous immunoassay for the detection of zolpidem in urine. Journal of analytical toxicology. 2009 Oct; 33(8):486-90. doi: 10.1093/jat/33.8.486. [PMID: 19874657]
  • Tomomi Ishida, Keiko Kudo, Makiko Hayashida, Noriaki Ikeda. Rapid and quantitative screening method for 43 benzodiazepines and their metabolites, zolpidem and zopiclone in human plasma by liquid chromatography/mass spectrometry with a small particle column. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2009 Sep; 877(25):2652-7. doi: 10.1016/j.jchromb.2009.05.008. [PMID: 19501029]
  • Manthena V S Varma, Bo Feng, R Scott Obach, Matthew D Troutman, Jonathan Chupka, Howard R Miller, Ayman El-Kattan. Physicochemical determinants of human renal clearance. Journal of medicinal chemistry. 2009 Aug; 52(15):4844-52. doi: 10.1021/jm900403j. [PMID: 19445515]
  • Selehattin Yilmaz. Adsorptive stripping voltammetric determination of zopiclone in tablet dosage forms and human urine. Colloids and surfaces. B, Biointerfaces. 2009 Jun; 71(1):79-83. doi: 10.1016/j.colsurfb.2009.01.007. [PMID: 19201168]
  • Shu Wing Kung, Man Li Tse, Yiu Cheung Chan, Fei Lung Lau, Sik Hon Tsui, Sidney Tam, Tak Shing Siu. Zopiclone-associated methemoglobinemia and renal impairment. Clinical toxicology (Philadelphia, Pa.). 2008 Dec; 46(10):1099-100. doi: 10.1080/15563650802382175. [PMID: 18949589]
  • R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1385-405. doi: 10.1124/dmd.108.020479. [PMID: 18426954]
  • L M McDonald, W F Sheppard, S M Staveley, B Sohal, F D Tattersall, P H Hutson. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats. Psychopharmacology. 2008 May; 197(4):591-600. doi: 10.1007/s00213-008-1077-z. [PMID: 18264695]
  • Hiren N Mistri, Arvind G Jangid, Ashutosh Pudage, Pranav Shrivastav. HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2008 Mar; 864(1-2):137-48. doi: 10.1016/j.jchromb.2008.02.004. [PMID: 18313371]
  • Juha Puustinen, Janne Nurminen, Matti Kukola, Tero Vahlberg, Kari Laine, Sirkka-Liisa Kivelä. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly. Drugs & aging. 2007; 24(12):1045-59. doi: 10.2165/00002512-200724120-00007. [PMID: 18020536]
  • Noreen Bannan, Siobhan Rooney, John O'connor. Zopiclone misuse: an update from Dublin. Drug and alcohol review. 2007 Jan; 26(1):83-5. doi: 10.1080/09595230601052777. [PMID: 17364840]
  • Aleksi Tornio, Pertti J Neuvonen, Janne T Backman. The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. European journal of clinical pharmacology. 2006 Aug; 62(8):645-51. doi: 10.1007/s00228-006-0155-6. [PMID: 16832679]
  • Ramakrishna V S Nirogi, Vishwottam N Kandikere, Koteshwara Mudigonda. Quantitation of zopiclone and desmethylzopiclone in human plasma by high-performance liquid chromatography using fluorescence detection. Biomedical chromatography : BMC. 2006 Aug; 20(8):794-9. doi: 10.1002/bmc.601. [PMID: 16292747]
  • Oscar Quintela, François-Ludovic Sauvage, Fabienne Charvier, Jean-Michel Gaulier, Gérard Lachâtre, Pierre Marquet. Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications. Clinical chemistry. 2006 Jul; 52(7):1346-55. doi: 10.1373/clinchem.2005.065631. [PMID: 16709625]
  • Jadwiga Najib. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clinical therapeutics. 2006 Apr; 28(4):491-516. doi: 10.1016/j.clinthera.2006.04.014. [PMID: 16750462]
  • Marleen Laloup, Maria del Mar Ramirez Fernandez, Gert De Boeck, Michelle Wood, Viviane Maes, Nele Samyn. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair. Journal of analytical toxicology. 2005 Oct; 29(7):616-26. doi: 10.1093/jat/29.7.616. [PMID: 16419390]
  • Jens D Mikkelsen, Andreas Søderman, Alexander Kiss, Naheed Mirza. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. European journal of pharmacology. 2005 Sep; 519(3):223-30. doi: 10.1016/j.ejphar.2005.06.049. [PMID: 16125698]
  • M Villain, M Chèze, A Tracqui, B Ludes, P Kintz. Testing for zopiclone in hair application to drug-facilitated crimes. Forensic science international. 2004 Oct; 145(2-3):117-21. doi: 10.1016/j.forsciint.2004.04.026. [PMID: 15451082]
  • David R Drover. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clinical pharmacokinetics. 2004; 43(4):227-38. doi: 10.2165/00003088-200443040-00002. [PMID: 15005637]
  • Hideaki Noguchi, Kazuhiro Kitazumi, Megumi Mori, Yoji Shiobara, Toshiharu Shiba. Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits. Journal of pharmacological sciences. 2003 Oct; 93(2):204-9. doi: 10.1254/jphs.93.204. [PMID: 14578589]
  • Naser Hussain, Martin MacKinnon, Ayub Akbari. Zopiclone-induced acute interstitial nephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003 May; 41(5):E17. doi: 10.1016/s0272-6386(03)00213-0. [PMID: 12778435]
  • Mario Giovanni Terzano, Mariano Rossi, Vincenzo Palomba, Arianna Smerieri, Liborio Parrino. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug safety. 2003; 26(4):261-82. doi: 10.2165/00002018-200326040-00004. [PMID: 12608888]
  • S A G Visser, F L C Wolters, J M Gubbens-Stibbe, E Tukker, P H Van Der Graaf, L A Peletier, M Danhof. Mechanism-based pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effects of GABAA receptor modulators: in vitro-in vivo correlations. The Journal of pharmacology and experimental therapeutics. 2003 Jan; 304(1):88-101. doi: 10.1124/jpet.102.042341. [PMID: 12490579]
  • Markus G Gebauer, Christopher P Alderman. Validation of a high-performance liquid chromatographic method for the enantiospecific quantitation of zopiclone in plasma. Biomedical chromatography : BMC. 2002 Jun; 16(4):241-6. doi: 10.1002/bmc.135. [PMID: 11933023]
  • Helena K Nordgren, Karl Bodin, Olof Beck. Chromatographic screening for zopiclone and metabolites in urine using liquid chromatography and liquid chromatography-mass spectrometry techniques. Therapeutic drug monitoring. 2002 Jun; 24(3):410-6. doi: 10.1097/00007691-200206000-00014. [PMID: 12021634]
  • Li-jun Yang, Gertrud Rochholz. [Determination of zopiclone in serum by reversed-phase high performance liquid chromatography]. Se pu = Chinese journal of chromatography. 2002 May; 20(3):256-8. doi: NULL. [PMID: 12541950]
  • Annemiek Vermeeren, Wim J Riedel, Martin P J van Boxtel, Mona Darwish, Isabelle Paty, Alain Patat. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep. 2002 Mar; 25(2):224-31. doi: 10.1093/sleep/25.2.224. [PMID: 11905433]
  • Christine Fernandez, Patrice Alet, Catherine Davrinche, Joelle Adrien, Alain Thuillier, Robert Farinotti, François Gimenez. Stereoselective distribution and stereoconversion of zopiclone enantiomers in plasma and brain tissues in rats. The Journal of pharmacy and pharmacology. 2002 Mar; 54(3):335-40. doi: 10.1211/0022357021778574. [PMID: 11902799]
  • C P Alderman, M G Gebauer, A L Gilbert, J T Condon. Possible interaction of zopiclone and nefazodone. The Annals of pharmacotherapy. 2001 Nov; 35(11):1378-80. doi: 10.1345/aph.1a074. [PMID: 11724087]
  • T R Norman, J Piccolo, N Voudouris, G D Burrows. The effect of single oral doses of zopiclone on nocturnal melatonin secretion in healthy male volunteers. Progress in neuro-psychopharmacology & biological psychiatry. 2001 May; 25(4):825-33. doi: 10.1016/s0278-5846(01)00157-9. [PMID: 11383979]
  • J Horák, B Cuparencu, A Horák. Effects of zopiclone on blood glucose level, serum lipid concentration and clot lysis time in normoglycemic and normolipidemic rats. Acta physiologica Hungarica. 2001; 88(2):139-44. doi: 10.1556/aphysiol.88.2001.2.6. [PMID: 11999806]
  • M Uchiumi, S Isawa, M Suzuki, M Murasaki. The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. 2000 Aug; 20(3):123-30. doi: NULL. [PMID: 11215153]
  • J Horák, B Cuparencu, A Horák. Acute effects of zopiclone on blood glucose level and serum lipids in hyperlipidemic rats. Interactions with PK 11195 and flumazenil. Acta physiologica Hungarica. 2000; 87(2):185-92. doi: NULL. [PMID: 11205967]
  • B Cuparencu, J Horák, A Horák, M Tiglea. Acute effects of zopiclone on blood glucose level and serum lipids in hyperlipidemic rats. Acta physiologica Hungarica. 2000; 87(2):193-9. doi: NULL. [PMID: 11205968]
  • B Feige, U Voderholzer, D Riemann, F Hohagen, M Berger. Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 1999 Nov; 110(11):1965-74. doi: 10.1016/s1388-2457(99)00147-9. [PMID: 10576495]
  • G Chouinard, K Lefko-Singh, E Teboul. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem. Cellular and molecular neurobiology. 1999 Aug; 19(4):533-52. doi: 10.1023/a:1006943009192. [PMID: 10379424]
  • C Fernandez, F Gimenez, A Thuillier, R Farinotti. Stereoselective binding of zopiclone to human plasma proteins. Chirality. 1999; 11(2):129-32. doi: 10.1002/(sici)1520-636x(1999)11:2<129::aid-chir8>3.0.co;2-e. [PMID: 9951403]
  • M Yamazaki, M Terada, Y Mitsukuni, M Yoshimura. [An autopsy case of poisoning by neuropsychopharmaceuticals including zopiclone]. Nihon hoigaku zasshi = The Japanese journal of legal medicine. 1998 Aug; 52(4):245-52. doi: NULL. [PMID: 9893443]
  • K Villikka, K T Kivistö, T S Lamberg, T Kantola, P J Neuvonen. Concentrations and effects of zopiclone are greatly reduced by rifampicin. British journal of clinical pharmacology. 1997 May; 43(5):471-4. doi: 10.1046/j.1365-2125.1997.00579.x. [PMID: 9159561]
  • E Mannaert, J Tytgat, P Daenens. Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection. Journal of analytical toxicology. 1997 May; 21(3):208-12. doi: 10.1093/jat/21.3.208. [PMID: 9171204]
  • R C Meatherall. Zopiclone fatality in a hospitalized patient. Journal of forensic sciences. 1997 Mar; 42(2):340-3. doi: NULL. [PMID: 9068198]
  • E Mannaert, J Tytgat, P Daenens. Development of a stereospecific radioimmunoassay for the analysis of zopiclone and metabolites in urine. Clinica chimica acta; international journal of clinical chemistry. 1996 Sep; 253(1-2):103-15. doi: 10.1016/0009-8981(96)06350-4. [PMID: 8879842]
  • K Mann, H Bauer, C Hiemke, J Röschke, H Wetzel, O Benkert. Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 1996 Aug; 6(3):163-8. doi: 10.1016/0924-977x(96)00014-4. [PMID: 8880074]
  • E Mannaert, P Daenens. Development of a fluorescence polarization immunoassay for the routine detection of N-desmethylzopiclone in urine samples. The Analyst. 1996 Jun; 121(6):857-61. doi: 10.1039/an9962100857. [PMID: 8763209]
  • H Luurila, K T Olkkola. Pharmacokinetic-pharmacodynamic modelling of zopiclone effects on human central nervous system. Pharmacology & toxicology. 1996 May; 78(5):348-53. doi: 10.1111/j.1600-0773.1996.tb01387.x. [PMID: 8737972]
  • F Stanke, N Jourdil, J Bessard, G Bessard. Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection. Journal of chromatography. B, Biomedical applications. 1996 Jan; 675(1):43-51. doi: 10.1016/0378-4347(95)00311-8. [PMID: 8634767]
  • G Hempel, G Blaschke. Enantioselective determination of zopiclone and its metabolites in urine by capillary electrophoresis. Journal of chromatography. B, Biomedical applications. 1996 Jan; 675(1):139-46. doi: 10.1016/0378-4347(95)00348-7. [PMID: 8634755]
  • K M Jalava, K T Olkkola, P J Neuvonen. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone. European journal of clinical pharmacology. 1996; 51(3-4):331-4. doi: 10.1007/s002280050207. [PMID: 9010708]
  • J Van Bocxlaer, E Meyer, K Clauwaert, W Lambert, M Piette, A De Leenheer. Analysis of zopiclone (Imovane) in postmortem specimens by GC-MS and HPLC with diode-array detection. Journal of analytical toxicology. 1996 Jan; 20(1):52-4. doi: 10.1093/jat/20.1.52. [PMID: 8837952]
  • C Fernandez, C Martin, F Gimenez, R Farinotti. Clinical pharmacokinetics of zopiclone. Clinical pharmacokinetics. 1995 Dec; 29(6):431-41. doi: 10.2165/00003088-199529060-00004. [PMID: 8787948]
  • K Otsubo, H Seto, K Futagami, R Oishi. Rapid and sensitive detection of benzodiazepines and zopiclone in serum using high-performance thin-layer chromatography. Journal of chromatography. B, Biomedical applications. 1995 Jul; 669(2):408-12. doi: 10.1016/0378-4347(95)00104-q. [PMID: 7581920]
  • K Aranko, H Luurila, J T Backman, P J Neuvonen, K T Olkkola. The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone. British journal of clinical pharmacology. 1994 Oct; 38(4):363-7. doi: 10.1111/j.1365-2125.1994.tb04367.x. [PMID: 7833227]
  • E Mannaert, P Daenens. Development of a radioimmunoassay for the determination of N-desmethylzopiclone in urine. The Analyst. 1994 Oct; 119(10):2221-6. doi: 10.1039/an9941902221. [PMID: 7992879]
  • R T Foster, G Caillé, A H Ngoc, C H Lemko, R Kherani, F M Pasutto. Stereospecific high-performance liquid chromatographic assay of zopiclone in human plasma. Journal of chromatography. B, Biomedical applications. 1994 Aug; 658(1):161-6. doi: 10.1016/0378-4347(94)00226-6. [PMID: 7952118]
  • B Ahrens, H Schütz, H Seno, G Weiler. Screening, identification and determination of the two new hypnotics zolpidem and zopiclone. Arzneimittel-Forschung. 1994 Jul; 44(7):799-802. doi: NULL. [PMID: 7945511]
  • D J Pounder, J I Davies. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. Forensic science international. 1994 May; 65(3):177-83. doi: 10.1016/0379-0738(94)90273-9. [PMID: 8039775]
  • M J Mattila, J Vanakoski, M E Mattila-Evenden, S L Karonen. Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects. European journal of clinical pharmacology. 1994; 46(3):215-20. doi: 10.1007/bf00192551. [PMID: 7915235]
  • C Fernandez, V Maradeix, F Gimenez, A Thuillier, R Farinotti. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. Drug metabolism and disposition: the biological fate of chemicals. 1993 Nov; 21(6):1125-8. doi: NULL. [PMID: 7905394]
  • H K Im, W B Im, B J Hamilton, D B Carter, P F Vonvoigtlander. Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors. Molecular pharmacology. 1993 Oct; 44(4):866-70. doi: NULL. [PMID: 7901754]
  • Y Gaillard, J P Gay-Montchamp, M Ollagnier. Gas chromatographic determination of zopiclone in plasma after solid-phase extraction. Journal of chromatography. 1993 Sep; 619(2):310-4. doi: 10.1016/0378-4347(93)80122-k. [PMID: 8263104]
  • C Fernandez, F Gimenez, B Baune, V Maradeix, A Thuillier, R Farinotti. Determination of the enantiomers of zopiclone and its two chiral metabolites in urine using an automated coupled achiral-chiral chromatographic system. Journal of chromatography. 1993 Aug; 617(2):271-8. doi: 10.1016/0378-4347(93)80498-s. [PMID: 8408393]
  • A Tracqui, P Kintz, P Mangin. High-performance liquid chromatographic assay with diode-array detection for toxicological screening of zopiclone, zolpidem, suriclone and alpidem in human plasma. Journal of chromatography. 1993 Jun; 616(1):95-103. doi: 10.1016/0378-4347(93)80476-k. [PMID: 8104192]
  • M J Royer-Morrot, M Rambourg, I Jacob, P Bauer, R J Royer. Determination of zopiclone in plasma using column liquid chromatography with ultraviolet detection. Journal of chromatography. 1992 Oct; 581(2):297-9. doi: 10.1016/0378-4347(92)80286-y. [PMID: 1452623]
  • V Saano, P P Hansen, P Paronen. Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. Pharmacology & toxicology. 1992 Feb; 70(2):135-9. doi: 10.1111/j.1600-0773.1992.tb00443.x. [PMID: 1508840]
  • C Fernandez, B Baune, F Gimenez, A Thuillier, R Farinotti. Determination of zopiclone enantiomers in plasma by liquid chromatography using a chiral cellulose carbamate column. Journal of chromatography. 1991 Dec; 572(1-2):195-202. doi: 10.1016/0378-4347(91)80483-s. [PMID: 1818054]
  • D Debruyne, J Lacotte, B Hurault de Ligny, M Moulin. Determination of zolpidem and zopiclone in serum by capillary column gas chromatography. Journal of pharmaceutical sciences. 1991 Jan; 80(1):71-4. doi: 10.1002/jps.2600800118. [PMID: 2013854]
  • T Kuitunen, M J Mattila, T Seppälä, K Aranko, M E Mattila. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. British journal of clinical pharmacology. 1990 Sep; 30(3):453-61. doi: 10.1111/j.1365-2125.1990.tb03797.x. [PMID: 2223424]
  • I Matheson, H A Sande, J Gaillot. The excretion of zopiclone into breast milk. British journal of clinical pharmacology. 1990 Aug; 30(2):267-71. doi: 10.1111/j.1365-2125.1990.tb03774.x. [PMID: 2206788]